Evaluation of Functional and Nutritional Parameters in Fit Acute Leukemia Patients
NCT ID: NCT06937554
Last Updated: 2025-04-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
30 participants
OBSERVATIONAL
2025-04-10
2025-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physical Activity Program and Nutrition Therapeutic Education During Treatment of Head and Neck Cancer Population
NCT01910753
Long Term Neurotoxic Effects of Chemotherapy in Survivors of Bone and Soft Tissue Sarcomas. A Retrospective Study
NCT02309242
Effects of Nutritional Counseling on Nutritional Status and Quality of Life of Head and Neck Cancer Patients
NCT03114202
An Investigation of Chemotherapy Induced Cognitive Impairments in Breast Cancer Survivors
NCT02515487
Exercise and Quality of Life in Leukemia Patients
NCT02246907
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
During the course of the study, the hematologists will manage the patients as per clinical practice and give clearance to perform each evaluation. All functional assessments and tests will be carried out by trained healthcare personnel with experience in the field of rehabilitation (either a Physical and Rehabilitation Medicine Resident, a Specialist, or a physiotherapist). A nutritionist will take care of assessing the nutritional aspects.
The aim of this study is to analyze the cognitive, physical and nutritional performance of AL patients hospitalized to receive intensive chemiotherapy (IC). Each item will be assessed at admission and discharge from the ward and after three weeks from the start of chemotherapy. Modifications of the considered items will be annotated and compared throughout the courses of chemotherapy, as well as relationship with indices of response and survival (Disease Free Survival, Overall Survival) will be explored. Such an effort will help further understanding how hematologic inpatients perform during IC treatment and what are the consequences on their quality of life and activities of daily living.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients above 18 years, affected by Acute Leukemia, performing intensive chemotherapy
observational follow up aimed at evaluating functional, physical, cognitive, and nutritional parameters
observational follow up aimed at evaluating functional, physical, cognitive, and nutritional parameters
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
observational follow up aimed at evaluating functional, physical, cognitive, and nutritional parameters
observational follow up aimed at evaluating functional, physical, cognitive, and nutritional parameters
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients affected by Acute Leukemia
* Inpatients performing intensive chemotherapy
* Patients with no restrictions on mobilization
* Signed written informed consent in accordance with ICH/EU/GCP guidelines and national and local laws.
Exclusion Criteria
* Any medical condition that the attending doctor judges as limiting to perform study related tasks
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Rome Tor Vergata
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nicola Manocchio
PhD Student, Medical Doctor, PRM Specialist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tor Vergata university Hospital
Rome, RM, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FisNutEma
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.